Cargando…
Targeting Glutathione S-transferase M4 in Ewing sarcoma
Ewing sarcoma is a malignant pediatric bone and soft tissue tumor. Although the 5-year survival rate of localized disease approaches 75%, the prognosis of metastatic and/or therapy-resistant disease remains dismal despite the wide use of aggressive therapeutic strategies. We previously reported that...
Autores principales: | Zhuo, Rupeng, Kosak, Kenneth M., Sankar, Savita, Wiles, Elizabeth T., Sun, Ying, Zhang, Jianxing, Ayello, Janet, Prestwich, Glenn D., Shami, Paul J., Cairo, Mitchell S., Lessnick, Stephen L., Luo, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123608/ https://www.ncbi.nlm.nih.gov/pubmed/25147782 http://dx.doi.org/10.3389/fped.2014.00083 |
Ejemplares similares
-
Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
por: Sankar, Savita, et al.
Publicado: (2012) -
Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2020) -
A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2023) -
Glutathione S-Transferases in Pediatric Cancer
por: Luo, Wen, et al.
Publicado: (2011) -
BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma
por: Wiles, Elizabeth T., et al.
Publicado: (2013)